Exodus Point Capital Management, LP Athersys, Inc Transaction History

Exodus Point Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.6 - $1.06 $29,328 - $51,812	-48,880 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.85 - $1.4 $17,385 - $28,635	20,454 Added 71.96%	48,880 $44,000
Q3 2021 Nov 15, 2021	SELL	$1.33 - $1.77 $22,608 - $30,088	-16,999 Reduced 37.42%	28,426 $38,000
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $24,253 - $33,369	-17,201 Reduced 27.47%	45,425 $65,000
Q1 2021 May 17, 2021	BUY	$1.61 - $2.77 $100,827 - $173,474	62,626 New	62,626 $113,000
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.24 $24,640 - $35,609	-15,897 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.91 - $3.08 $593,246 - $956,648	-310,600 Reduced 95.13%	15,897 $31,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $643,199 - $1.3 Million	326,497 New	326,497 $901,000
Q1 2020 May 15, 2020	SELL	$1.17 - $3.0 $41,821 - $107,235	-35,745 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.16 - $1.42 $41,464 - $50,757	35,745 New	35,745 $44,000
Q2 2019 Aug 14, 2019	SELL	$1.39 - $2.03 $30,051 - $43,888	-21,620 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.39 - $1.71 $30,051 - $36,970	21,620 New	21,620 $32,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.